Cetera Advisor Networks’s Catalyst Pharmaceutical CPRX Stock Holding History

Cetera Advisor Networks’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-10,857	Closed	-$183K	–	2834
2023 Q4	$183K	Buy	10,857 +432	+4%	+$5.91K	﹤0.01%	2561
2023 Q3	$122K	Buy	+10,425	New	+$139K	﹤0.01%	2539
2022 Q3	–	Sell	-21,308	Closed	-$149K	–	2105
2022 Q2	$149K	Hold	21,308	–	–	﹤0.01%	1908
2022 Q1	$177K	Buy	21,308 +1,262	+6%	+$8.92K	﹤0.01%	1921
2021 Q4	$136K	Buy	+20,046	New	+$132K	﹤0.01%	1936
2014 Q2	–	Sell	-24,000	Closed	-$54K	–	804
2014 Q1	$54K	Sell	24,000 -4,000	-14%	-$8.36K	﹤0.01%	765
2013 Q4	$56K	Hold	28,000	–	–	﹤0.01%	748
2013 Q3	$85K	Buy	+28,000	New	+$47.1K	0.01%	673

Other funds holding CPRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cetera Advisor Networks's CPRX Position: Q1 2024 in Review

Cetera Advisor Networks sold out of Catalyst Pharmaceutical (CPRX) in Q1 2024, closing a stake of 10,857 shares — an estimated $183K sold.

Cetera Advisor Networks first reported a position in CPRX in Q3 2013 and held it in 8 quarters. The position peaked at $183K in Q4 2023. 269 funds tracked by Wall St. Rank hold CPRX as of Q1 2024.

Cetera Advisor Networks reported no remaining Catalyst Pharmaceutical position as of Q1 2024 after selling out during the quarter.
Cetera Advisor Networks sold 10,857 Catalyst Pharmaceutical shares in Q1 2024, an estimated $183K.
Cetera Advisor Networks first reported a position in Catalyst Pharmaceutical in Q3 2013 and held it in 8 quarters.
Cetera Advisor Networks's Catalyst Pharmaceutical position peaked at $183K in Q4 2023.
269 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.